Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis
- 12 April 1991
- journal article
- Published by Elsevier in Brain Research
- Vol. 546 (1) , 40-46
- https://doi.org/10.1016/0006-8993(91)91156-u
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine — an in vivo dialysis study in freely moving ratsBrain Research, 1990
- The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitroLife Sciences, 1988
- Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpirideEuropean Journal of Pharmacology, 1987
- Topography of substantia nigra innervation by D1 receptor-containing striatal neuronsBrain Research, 1987
- Modulation of In Vivo Dopamine Release by D2 but Not D1 Receptor Agonists and AntagonistsJournal of Neurochemistry, 1987
- Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonistsEuropean Journal of Pharmacology, 1986
- Dendritic release of dopamine in the substantia nigraNature, 1981
- The Antagonism of Amphetamine-Induced Symptomatology by a NeurolepticAmerican Journal of Psychiatry, 1974
- Evolving Behavior in the Clinical and Experimental Amphetamine (Model) PsychosisAmerican Journal of Psychiatry, 1973
- The Experimental Reproduction of Amphetamine PsychosisArchives of General Psychiatry, 1973